SCTIMST successfully performs first LDL apheresis procedure for treating Familial Hypercholesterolemia
Doctors at the Sree Chitra Tirunal Institute for Medical Sciences and Technology have performed the facility's first LDL apheresis procedure. This treatment helps manage Homozygous Familial Hypercholesterolemia, a rare genetic condition causing dangerously high cholesterol.
Why it matters
This medical milestone provides a life-saving treatment option for patients with severe genetic cholesterol disorders who do not respond to traditional medication.
The departments of Cardiology and Transfusion Medicine at Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) has successfully performed its first LDL (bad cholesterol) apheresis procedure on a 34-year-old woman suffering from Homozygous Familial Hypercholesterolemia (HoFH), a rare genetic condition, which results in extremely high cholesterol levels from a young age.
The article is a straightforward report on a medical procedure and institutional achievement.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in